Aveo Pharmaceutical

Why We Expect The FDA To Approve Aveo's Tivozanib
Seeking Alpha
Tue, 04/16/13 - 10:52 am
FDA
tivozanib
Aveo Pharmaceutical
renal cell carcinoma
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
3 Small Cap Biopharmas Primed To Move Much Higher Now
Seeking Alpha
Wed, 03/27/13 - 12:27 pm
Acadia
Aveo Pharmaceutical
Sarepta
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Thu, 03/14/13 - 10:51 am
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Arena Pharmaceuticals
Sarepta
Ziopharm
Delcath
Aveo Pharmaceutical
United Therapeutics
AP Pharma
Titan Pharmaceuticals
Navidea Biopharmaceuticals
Biogen Idec
Raptor Pharmaceuticals
AVEO: Final Overall Survival Results From The TIVO­1 Study
Seeking Alpha
Thu, 02/14/13 - 11:18 am
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Aveo Pharma Readies Survival Update For Kidney Cancer Drug
TheStreet.com
Mon, 02/4/13 - 11:22 am
Aveo Pharmaceutical
kidney cancer
tivozanib
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Upcoming FDA Decision For AVEO's Tivozanib Builds Speculation
Seeking Alpha
Sat, 12/22/12 - 12:23 pm
Aveo Pharmaceutical
tivozanib
ONYX Pharmaceuticals
Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
Seeking Alpha
Mon, 12/10/12 - 12:30 pm
Aveo Pharmaceutical
tivozanib
Pfizer
ONYX Pharmaceuticals
Novartis
GSK
Eli Lilly
Exelixis
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
6 Biotech Stocks That Could Be In For A Short Squeeze
Seeking Alpha
Mon, 08/20/12 - 11:38 am
Aveo Pharmaceutical
BioTime
ChemoCentryx
Optimer Pharmaceuticals
Clovis Oncology
PDL Biopharma
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost
Motley Fool
Sat, 03/24/12 - 11:30 am
Celldex
Arqule
JNJ
Ariad Pharmaceuticals
Aveo Pharmaceutical
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Thu, 02/23/12 - 10:42 am
Vertex Pharmaceuticals
Acorda
Aveo Pharmaceutical
Jazz Pharmaceuticals
Momenta
AVEO: More Open Questions Than Answers
Seeking Alpha
Sun, 01/8/12 - 12:47 pm
Aveo Pharmaceutical
tivozanib
kidney cancer
renal cancer
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus

Pages